MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Utilizing remote blood pressure monitoring in a phase III clinical drug trial for Parkinson’s disease

    J.L. Adams, R.A. Biemiller, K.L. Andrzejewski, S. Sharma, R.L. Rockhill, B.L. Greco, K.C. Hodgeman, P. Singh, S. Khanuja, T. Simuni, K.M. Biglan (Rochester, NY, USA)

    Objective: To determine the feasibility and value of remote blood pressure (BP) monitoring during a clinical trial of isradipine (a dihydropyridine calcium channel antagonist) in…
  • 2016 International Congress

    Regional differences in the results of a phase 2b study of tozadenant in Parkinson’s disease patients with motor fluctuations

    C. Kenney, K. Kieburtz, W. Olanow, S. Bandak (San Francisco, CA, USA)

    Objective: To assess how the efficacy of tozadenant differed by region in a randomized, double-blind, placebo-controlled trial of Parkinson's disease patients with motor fluctuations. Background:…
  • 2016 International Congress

    The study of clinical outcome of deep brain stimulation for the idiopathic Parkinson’s disease at 6 months follow-up

    P. Papitak, M. Aphiwatthanakun, T. Srikijvilaikul, N. Limotai (Bangkok, Thailand)

    Objective: The aim of this study was to assess the motor and psychiatric outcomes at 6 months after subthalamic nucleus deep brain stimulation (STN-DBS) in…
  • 2016 International Congress

    Difference between physiologically defined subthalamic nucleus target and final lead placement: Influence in clinical outcome

    A. Medina, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate distance between the physiologically defined subthalamic nucleus (STN) target and final lead placement, and its influence on the clinical outcome at 6…
  • 2016 International Congress

    Successful DBS: Doctors happy, patients not – Why?

    M.H. Strothjohann, B. Holzinger, G.A. Fuchs, F. Weber (Bad Camberg, Germany)

    Objective: Deep brain stimulation (DBS) in Parkinson's disease (PD) has been proven successful; however, not in all. Background: We report on 5 PD patients who…
  • 2016 International Congress

    Comparison of four DBS lead designs under voltage and current operating modes based on patient specific simulations

    F. Alonso, N. Göransson, P. Zsgimond, K. Wårdell (Linköping, Sweden)

    Objective: To quantitatively compare the spatial extension of the electric field generated by four different lead designs operated under voltage and current modes. Background: Conventional…
  • 2016 International Congress

    A prospective study of patients’ expectations in subthalamic nucleus deep brain stimulation for Parkinson’s disease

    N.R. Mundil, H.Y. Ling, H. Hasegawa, M. Samuel, K. Ashkan (London, United Kingdom)

    Objective: To prospectively assess the long-term outcome of subthalamic nucleus (STN) deep brain stimulation (DBS) and the relationship with patients' expectations and satisfaction. Background: Subthalamic…
  • 2016 International Congress

    Cognitive outcome in the patients with Parkinson’s disease one year after subthalamic implants in Taiwan

    Y.F. Chen, C.C. Chang, W.F. Chen, F.Y. Shih, M.Y. Lan, T.K. Lin, Y.F. Chen, Y.Y. Chang (Kaohsiung, Taiwan)

    Objective: To demonstrate cognitive outcome after subthalamic deep brain stimulation(DBS) in the patients with Parkinson's disease(PD) in Taiwan. Background: Deep brain stimulation of the subthalamic…
  • 2016 International Congress

    DTI tractographic correlates of weight gain in Parkinson’s disease patients after STN DBS

    O.F. Ahmad, L. Huang, N. Vanegas-Arroyave, K. Zaghloul, S.G. Horovitz, C. Lungu (Bethesda, MD, USA)

    Objective: To assess DTI connectivity patterns and correlations with weight gain in Parkinson's disease patients after STN DBS. Background: Weight gain is a well-known adverse…
  • 2016 International Congress

    Prospective evaluation of pallidal deep brain stimulation in Huntington’s disease

    S. Zittel, V. Tadic, C. Moll, A. Fellbrich, N. Brüggemann, D. Rasche, T. Bäumer, V. Tronnier, A. Münchau (Luebeck, Germany)

    Objective: To prospectively evaluate the effect of bilateral pallidal deep brain stimulation (DBS) on motor symptoms, activities of daily living and quality of life in…
  • « Previous Page
  • 1
  • …
  • 108
  • 109
  • 110
  • 111
  • 112
  • …
  • 207
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley